No consistent evidence shows that routine multivitamin use improves major health outcomes such as all-cause mortality, cardiovascular events, or cancer incidence in well-nourished adults without identified defi...
Why this question matters
For adults who already get adequate nutrition, routine multivitamin use has not consistently been linked with better major health outcomes such as lower mortality, cardiovascular events, or cancer incidence. Multivitamins can still be appropriate in specific situations involving deficiency risk, restricted diets, pregnancy planning, or clinician-directed supplementation.
The claim being judged
The claim is that multivitamins improve health outcomes in well-nourished adults. In this context, “well-nourished” means adults without a known vitamin or mineral deficiency, without a medical condition causing malabsorption, and without a life stage or diet pattern that clearly requires targeted supplementation.
The claim is not mainly about whether vitamins are essential nutrients. They are. The question is whether taking a broad multivitamin, on top of an already adequate diet, leads to measurable improvements in outcomes that matter to health, such as living longer, fewer heart attacks or strokes, lower cancer risk, better cognition, fewer infections, or improved quality of life.
It is also important to distinguish multivitamins from specific, targeted supplements. Folic acid before and during early pregnancy, vitamin B12 for some vegans or older adults, vitamin D in selected deficient groups, and iron for iron deficiency are different questions from routine multivitamin use by adults with adequate nutrient intake.
What the evidence shows
Large randomized trials and systematic reviews have generally found limited evidence that routine multivitamin use improves major clinical outcomes in well-nourished adult populations. Findings for all-cause mortality, cardiovascular disease, and overall cancer incidence have typically been small, inconsistent, or not statistically persuasive across studies.
The U.S. Preventive Services Task Force has concluded that evidence is insufficient to assess the balance of benefits and harms for multivitamin use to prevent cardiovascular disease or cancer in nonpregnant adults. This does not mean every formulation has been studied equally, but it reflects the overall uncertainty and limited signal for broad preventive benefit in the general adult population.
Some studies report possible benefits for selected endpoints or subgroups, such as modest cognitive findings in older adults in some trials or cancer-related signals in particular cohorts. These findings are important to examine, but they do not yet establish that a typical well-nourished adult should expect broad health improvements from daily multivitamin use.
Harms from standard-dose multivitamins are usually considered low for many adults, but “low risk” is not the same as clear benefit. Potential concerns include excessive intake of certain nutrients when combined with fortified foods, interactions with medications, false reassurance about diet quality, and costs over time.
Where uncertainty remains
Uncertainty remains because multivitamin products vary widely in nutrient content, dosing, bioavailability, and quality control. Trial populations also differ in baseline diet quality, age, health status, supplement adherence, and length of follow-up, which can affect whether small benefits or harms are detected.
It is also possible that specific groups within the broad category of “well-nourished adults” may respond differently. Older adults, people with low-normal nutrient status, people with limited sun exposure, or those taking medications that affect nutrient absorption may need individualized assessment even if they appear generally healthy.
Future evidence would be most useful if it separated well-nourished participants from those with deficiency risk, used clearly described formulations, measured long-term clinical outcomes, and reported subgroup results without overinterpreting chance findings.
The three parts of the claim
The umbrella claim is actually several claims bundled into one. Each needs its own evaluation.
Model comparison
How each panel model rated the three parts of the claim| Model | Part 1 | Part 2 | Part 3 | Overall |
|---|---|---|---|---|
| Grok 4.3 | No · 78% | No · 74% | Yes · 86% | Mixed · 70% |
| Mistral Medium 3.5 | No · 78% | No · 74% | Yes · 86% | Mixed · 85% |
| OpenAI GPT-5.4 | No · 78% | No · 74% | Yes · 86% | Mixed · 70% |
| Llama 4 Maverick | No · 78% | No · 74% | Yes · 86% | No · 70% |
| Gemini 3.1 Pro | No · 78% | No · 74% | Yes · 86% | Mixed · 70% |
| Claude Opus 4.7 | No · 78% | No · 74% | Yes · 86% | Mixed · 85% |
| DeepSeek V4 Pro | No · 78% | No · 74% | Yes · 86% | No · 85% |
| GLM 5.1 | No · 78% | No · 74% | Yes · 86% | Mixed · 85% |
| Kimi K2.6 | — | — | — | Incomplete |
| Qwen 3.7 Max | No · 78% | No · 74% | Yes · 86% | Mixed · 85% |
What would change our mind
The current evidence leans one way. But we're not committed to the conclusion, we're committed to the evidence.
- Large, well-conducted randomized trials in demonstrably well-nourished adults showing meaningful reductions in all-cause mortality, cardiovascular events, cancer incidence, or other major clinical outcomes from a defined multivitamin formulation.
- Consistent meta-analytic evidence showing benefits across multiple independent trials without offsetting safety concerns or strong evidence of publication bias.
- Clear evidence that a specific subgroup of otherwise well-nourished adults has reproducible clinical benefit, along with practical criteria for identifying that subgroup.
- Long-term safety data showing that routine multivitamin use does not increase risks from excessive nutrient intake, medication interactions, or other adverse outcomes in common real-world use.
- Evidence comparing routine multivitamin use with targeted testing-and-supplementation strategies, showing that broad multivitamin use produces better patient-centered outcomes.
Common questions
References
Guideline
Systematic Review
Trial
Government Resource
Consensus Statement
What each model said
Routine multivitamin use does not improve major health outcomes (all-cause mortality, cardiovascular disease, or cancer incidence) in well-nourished adults. High confidence in this conclusion is supported by mu...
Mostly accurate. Confidence: 0.87 In well-nourished adults, routine multivitamin use does not have good evidence of improving major health outcomes, and the claim reflects the current mainstream evidence base r...
Multivitamins do not consistently improve major health outcomes in well-nourished adults. The confidence in this assessment is high, based on multiple large-scale randomized controlled trials and systematic rev...
Routine multivitamin use does not significantly improve major health outcomes, such as reducing all-cause mortality, cardiovascular disease, or overall cancer incidence, in well-nourished adults. While they do...
For well-nourished adults, routine multivitamin use has not been shown to meaningfully improve major health outcomes such as all-cause mortality, cardiovascular events, or overall cancer incidence. The claim, a...
In well-nourished adults without specific micronutrient deficiencies, routine multivitamin use has not been shown to improve major health outcomes. Large systematic reviews and randomized trials consistently fi...
Routine multivitamin use does not improve major health outcomes such as all-cause mortality, cardiovascular disease, or overall cancer incidence in well-nourished adults, though they remain beneficial for indiv...
Incomplete response: output limit reached before a parseable answer.
Multivitamins do not consistently improve major health outcomes, such as all-cause mortality, cardiovascular disease, or overall cancer incidence, in well-nourished adults. However, they are beneficial and clin...